LifePoint (LPNT) Sells Unit To Focus On High-Growth Markets
Zacks Investment Research | Oct 02, 2017 09:22PM ET
LifePoint Health, Inc. (NASDAQ:LPNT) has completed the sale of its ownership interest in Rockdale Medical Center and associated assets to Piedmont Healthcare, an Atlanta-based healthcare delivery system.
LifePoint Health now operates more than 70 hospital campuses and regional health systems, as well as physician practices, outpatient centers, and post-acute service providers in 22 states.
The company has undertaken a number of divestitures in recent years to realign its business and focus on growing in new attractive markets.
Year to date, the stock has gained 3.3%, which is almost in line with the industry’s growth of 3.8%.
Some of its recent divestitures include the sale of Putnam Community Medical Center, Lakeland Community Hospital, Northwest Medical Center and Russellville Hospital and River Parishes Hospital.
The funds from these divestitures are being used to lower its high debt level and pursue accretive acquisitions in high-growth markets. The company has sealed a number of acquisitions and strategic partnerships in recent years.
These deals have supplemented the company’s efforts to achieve organic growth in its existing markets. Newly acquired hospitals have accounted for the majority of the company’s growth.
From 2014-2016, acquisitions provided significant EBITDA growth opportunities. The acquisitions are in a transitional phase of outsized margin improvement in 2017, moving toward low double-digit margins. Earlier, the company said that it expects contribution to net revenues ($6.5 billion to $6.6 billion guided) of more than $2 billion and approximately $55 million of incremental adjusted EBITDA in 2017.
LifePoint carries a Zacks Rank #4 (Sell). Some better-ranked stocks in the healthcare sector are UnitedHealth Group Inc. (NYSE:UNH) , Centene Corp. (NYSE:CNC) and Select Medical Holdings, Corp. (NYSE:SEM) . Each of these stocks carries a Zacks Rank #2 (Buy). You can see .
UnitedHealth Group, one of the leading diversified health and well-being companies has seen its Zacks Consensus Estimate for 2017 and 2018 being revised upward by 1% and 0.2%, respectively, in the past 90 days.
Centene, a multi-national healthcare company of the United States witnessed its Zacks Consensus Estimate for 2017 and 2018 being revised upward by 3.4% and 2.4%, respectively, in the past 90 days.
Get The News You Want
Select Medical, another leading managed care company has also seen its Zacks Consensus Estimate for 2017 and 2018 being revised upward by 7% and 10%, respectively, in the past 90 days. The company posted positive surprises in the last two quarters as well.
Will You Make a Fortune on the Shift to Electric Cars?
Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.
With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.
It's not the one you think.
Original post
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.